Faculty

Targeted therapy and immunotherapy for hematological malignancies

1. Eray Yihui Zhou, Fan Yu, Yanying Wang, Yalan Bi, Hsiaohan Tuan, Yuehua Huang, Bianhong Wang, Jingxian Li, Hongfang Yin, Lihong Li*, Yi Zhao*.Clinical and pathological evaluation of cladribine treatment response in a case series of patients with xanthoma disseminatum. Eur J Dermatol. 2023 Jun 1;33(3):270-279. doi: 10.1684/ejd.2023.4502.

2. Yuehua Huang, Yanying Wang, Fan Yu, Xuehan Mao, Bianhong Wang, Jingxian Li, Lihong Li*. Case Report: Therapeutic Use of Ibrutinib in a Patient With Schnitzler Syndrome. Front Immunol. 2022 Apr 20;13:894464. doi: 10.3389/fimmu.2022.894464. eCollection 2022.

3. Yu F, Huang Y, Wang Y, Yu Z, Li X, Dong J. Very late onset post-transplant diffuse large B cell lymphoma in a liver transplant recipient with hepatitis B: A case report. Medicine (Baltimore). 2018 Nov;97(44):e13063. IF: 2.028.

4. Yu F, Du Y, Han B. A comparative analysis of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria between Asia and Europe/America. Int J Hematol. 2016 Jun;103(6):649-54. IF: 1.846.

5. Long Z, Yu F, Du Y, Li H, Chen M, Zhuang J, Han B. Successful treatment of refractory/relapsed acquired pure red cell aplasia with sirolimus. Ann Hematol. 2018 Nov;97(11):2047-2054. IF: 2.845.

6. Li H, Wang L, Wu Y, Su L, Zhao H, Zhang Y, Wang Z, Huang D, Huang Z, Wu X, Li X, Ye F, Yu F, Liu H, Wang JW, Cong J, Sun W, Chen HR, Wang J, Han B. Very-Low-Dose Decitabine Is Effective in Treating Intermediate- or High-Risk Myelodysplastic Syndrome. Acta Haematol. 2017;138(3):168-174.IF:1.307.

7. Eiring AM, Khorashad JS, Anderson DJ, Yu F, Redwine HM, Mason CC, Reynolds KR, Clair PM, Gantz KC, Zhang TY, Pomicter AD, Kraft IL, Bowler AD, Johnson K, Partlin MM, O'Hare T, Deininger MW. β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia. Leukemia. 2015 Dec;29(12):2328-37. IF:10.431.

8. Khorashad JS, Eiring AM, Mason CC, Gantz KC, Bowler AD, Redwine HM, Yu F, Kraft IL, Pomicter AD, Reynolds KR, Iovino AJ, Zabriskie MS, Heaton WL, Tantravahi SK, Kauffman M, Shacham S, Chenchik A, Bonneau K, Ullman KS, O'Hare T, Deininger MW. shRNA library screening identifies nucleocytoplasmic transport as a mediator of BCR-ABL1 kinase-independent resistance. Blood. 2015 Mar 12;125(11):1772-81. IF: 10.452.

9. Zhi L, Wang M, Rao Q, Yu F, Mi Y, Wang J. Enrichment of N-Cadherin and Tie2-bearing CD34+/CD38-/CD123+ leukemic stem cells by chemotherapy-resistance. Cancer Lett. 2010 Oct 1;296(1):65-73. IF: 4.864.

In 2013, won the third prize in the first Youth Teacher Lecture Competition at Beijing Tsinghua Changgung Hospital;

In 2015, awarded the title of "Good Teacher in the Heart of Residents" by Beijing Tsinghua Changgung Hospital;

In 2015, awarded Outstanding Paper at the 15th National Conference on Red Blood Cell Disease (Anemia) of the Chinese Medical Association;

Made significant contributions to the work of Beijing Tsinghua Changgung Hospital in 2020 and received commendation;

Won Excellent Award in the 2020 National Blood Disease Practical Competition;

In 2021, awarded the title of "Outstanding Worker" by Beijing Tsinghua Changgung Hospital;

In 2022, awarded the title of "Service Model" by Beijing Tsinghua Changgung Hospital.

Member of the Hematology Oncology Professional Committee of the Beijing Society of Integrative Medicine;

Member of the Hematology Professional Committee of the Beijing Perioperative Medical Research Association;

Member of the Lymphoma Immunotherapy Professional Committee of the Beijing Cancer Prevention and Treatment Society.